Advertisement
Should you worry about ACA hikes?

Should you worry about ACA hikes?

By Shelby Livingston  |  October 29, 2016

Policy experts say the projected double-digit hikes are unlikely to affect the majority of people who enroll in health plans through the federal exchange. At the same time, benchmark premiums in some states, including Arkansas, Indiana and Ohio, will increase only slightly or even decrease in 2017.

Baby boomers, drugs pushing up federal healthcare spending

By Shannon Muchmore  |  August 23, 2016

Federal spending for major healthcare programs are estimated to increase by $55 billion, or 6%, in 2016 after a technical adjustment for payment timing shifts, according to a report from the Congressional Budget Office.

Fixing the insurance exchanges

Fixing the insurance exchanges

By Bob Herman  |  August 06, 2016

Industry and regulatory fixes to the ACA marketplaces appear inevitable as impatience and insurer losses escalate.

Editorial: Why assume healthcare cost controls will fail?

Editorial: Why assume healthcare cost controls will fail?

By Merrill Goozner  |  July 16, 2016

Last week, two well-respected groups of government economists predicted the end is nigh for the era of restrained growth in healthcare spending. Ignore them. They've been wrong before. They will be proven wrong again.

What, me buy insurance?

What, me buy insurance?

By Bob Herman  |  May 14, 2016

The tax penalty and other measures designed to get younger, healthier people to sign up for individual plans on the ACA's insurance exchanges have not accomplished their mission of preventing adverse selection.

Q&A: Universal Health CEO believes Obamacare is here to stay

Q&A: Universal Health CEO believes Obamacare is here to stay

By Modern Healthcare  |  May 14, 2016

Alan Miller, chairman and CEO of Universal Health Services, recently spoke with Modern Healthcare senior reporter Harris Meyer about the reasons for the company's improving financial performance at a time when some other for-profit hospital chains are struggling.

Q&A: 'Drug prices are the wrong target,' says PhRMA chief

Q&A: 'Drug prices are the wrong target,' says PhRMA chief

By Modern Healthcare  |  April 30, 2016

A nimble inside-the-Beltway operative, Stephen Ubl took the reins of the Pharmaceutical Research and Manufacturers of America just as outrage over high drug prices was hitting its peak. In an interview with Modern Healthcare Editor Merrill Goozner, Ubl shares his views on the drug-price debate.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print